US DOD to fund Humanetics’ new drug test against Covid-19

By PBR Staff Writer

The US Department of Defense (DOD) has approved the funding of US-based private pharmaceutical firm Humanetics to test its drug candidate BIO 300 in treating pulmonary inflammation triggered by COVID-19.